Pediatric immunity refers to the complex and dynamic defense mechanisms that protect children from infections and maintain overall health. The immune system in children undergoes developmental changes from birth through adolescence, adapting to confront diverse pathogens while avoiding inappropriate responses to harmless substances. Neonatal immunity is initially influenced by maternal antibodies transferred during pregnancy and breastfeeding, providing passive protection. As infants grow, their immune system matures, and they develop active immunity through vaccination and exposure to pathogens. Pediatric immunity includes innate and adaptive components, involving various immune cells, antibodies, and cytokines. Early exposure to microbes helps shape the immune system's ability to distinguish between self and non-self, fostering tolerance. Vaccination plays a crucial role in pediatric immunity, preventing severe infectious diseases. Factors such as nutrition, genetics, and environmental exposures also impact immune development in children. Understanding pediatric immunity is essential for optimizing vaccination strategies, managing infections, and promoting overall well-being in pediatric populations. Ongoing research continues to enhance our knowledge of pediatric immune responses and inform strategies to improve child health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States